Arbutus Biopharma Corp. (ABUS)
4.20
-0.01
(-0.24%)
USD |
NASDAQ |
Oct 23, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price to Book Value : 3.208 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.208 |
| October 22, 2026 | 3.216 |
| October 21, 2026 | 3.193 |
| October 20, 2026 | 3.308 |
| October 19, 2026 | 3.231 |
| October 16, 2026 | 3.224 |
| October 15, 2026 | 3.277 |
| October 14, 2026 | 3.200 |
| October 13, 2026 | 3.139 |
| October 12, 2026 | 3.17 |
| October 09, 2026 | 3.224 |
| October 08, 2026 | 3.193 |
| October 07, 2026 | 3.277 |
| October 06, 2026 | 3.422 |
| October 05, 2026 | 3.567 |
| October 02, 2026 | 3.399 |
| October 01, 2026 | 3.483 |
| September 30, 2026 | 3.651 |
| September 29, 2026 | 3.582 |
| September 28, 2026 | 3.712 |
| September 25, 2026 | 3.705 |
| September 24, 2026 | 3.728 |
| September 23, 2026 | 3.705 |
| September 22, 2026 | 3.827 |
| September 21, 2026 | 3.819 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.827 |
| September 17, 2026 | 3.873 |
| September 16, 2026 | 3.858 |
| September 15, 2026 | 3.865 |
| September 14, 2026 | 3.919 |
| September 11, 2026 | 3.911 |
| September 10, 2026 | 3.911 |
| September 09, 2026 | 3.949 |
| September 08, 2026 | 3.957 |
| September 04, 2026 | 3.934 |
| September 03, 2026 | 3.911 |
| September 02, 2026 | 3.896 |
| September 01, 2026 | 3.888 |
| August 31, 2026 | 3.880 |
| August 28, 2026 | 3.873 |
| August 27, 2026 | 3.949 |
| August 26, 2026 | 3.964 |
| August 25, 2026 | 3.972 |
| August 24, 2026 | 3.972 |
| August 21, 2026 | 3.980 |
| August 20, 2026 | 3.644 |
| August 19, 2026 | 3.804 |
| August 18, 2026 | 3.697 |
| August 17, 2026 | 3.598 |
| August 14, 2026 | 3.567 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gossamer Bio, Inc. | -- |
| Legend Biotech Corp. | 3.037 |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
Price to Book Value Related Metrics
| PE Ratio | 5.361 |
| PS Ratio | 4.490 |
| Price | 4.20 |
| Earnings Yield | 18.65% |
| Market Cap | 830.06M |
| Operating PE Ratio | 5.534 |
| Normalized PE Ratio | 5.401 |